PHAMARCEUTICAL INDUSTRY AND EVOLUTION IN NIGERIA.PART 12

He noted vividly,from absolute criteria such as cost considerations to the risk adjusted rate of return profile,on investment,he told audience pointblank were deplorably negative and comparatively low.He cited reason why global majors were not investment and their apathy."It is not surprising that the global majors in the industry are not pouring in capital. Estimated at about $1billion,(less than 0.5percent of Nigeria's GDP and basically the size of a medium sized phamarceutical company abroad)..."and lamented the share of the nation's phamarceutical industry globally is absolutely zero. That they have been consistently loosing market share at home,let alone competitive overseas.That it is a sorry state that none of the drug companies locally is WHO certified and when adjusted for the outsourced foreign firms'production,about a hundred local drug companies,basically small or fragmented cannot account for20percent of the industry domestic drug consumption output.Some of the local firms have joined importers.